W. C. Hsu, W. H. Chen, M. T. Chang and H. C. Chiu, “Colchicine-Induced Acute Myopathy in a Patient with Concomitant Use of Simvastatin,” Clinical Neuropharmacology, Vol. 25, No. 5, September-October 2002, pp.266-8.
 G. Alayli, K. Cengiz, F. Cantürk, D. Durmus, Y. Akyol, E.B. Menekse, “Acute Myopathy in a Patient with Concomitant Use of Pravastatin and Colchicines” Annals of Pharmacotherapy, Vol. 39, No. 5, July-August 2005, pp. 1358-1361.
 I. Akdag, A. Ersoy, S. Kahvecioglu, M. Gullulu and K. Dilek, “Acute Colchicine Intoxication during Clarithromycin Administration in Patients with Chronic Renal Failure” Journal of Nephrology, Vol. 19, No. 4, July- August 2006, pp. 515-517.
 I. F. Hung, A. K. Wu, V. C. Cheng, B. S. Tang, K. W. To, C. K. Yeung, P. C. Woo, S. K. Lau, B. M. Cheung and K. Y. Yuen, “Fatal Interaction between Clarithromycin and Colchicine in Patients with Renal Insuf?ciency: A Retrospective Study,” Clinical Infectious Diseases, Vol. 41, No. 3, August 2005, pp. 291-300.
 M. Katoh, M. Nakajima, H. Yamazaki and H. T. Yokoi, “Inhibitory Effects of CYP3A4 Substrates and their Metabolites on P-Glycoprotein-Mediated Transport,” European Journal of Pharmaceutical Sciences, Vol. 12, No. 4, February 2001, pp. 505-513.
 C. A. Naranjo, U. Busto, E. M. Sellers, P. Sandor, I. Ruiz, E. A. Roberts, E. Janecek, C. Domecq and D. J. Greenblatt, “A Method for Estimating the Probability of Adverse Drug Reactions,” Clinical Pharmacology Therapeutics, Vol. 30, No. 2, August 1981, pp. 239-245.